|1.||Ravaioli, Giulia: 1 article (08/2008)|
|2.||Vafeiadou, Katerina: 1 article (08/2008)|
|3.||Spencer, Jeremy P E: 1 article (08/2008)|
|4.||Vauzour, David: 1 article (08/2008)|
|5.||Angeloni, Cristina: 1 article (08/2008)|
|6.||Rodriguez-Mateos, Ana: 1 article (08/2008)|
|1.||Neurodegenerative Diseases (Neurodegenerative Disease)
10/01/1992 - "These observations suggest that if DHBT is formed as an aberrant metabolite of 5-HT in the human brain, it could potentially be neurotoxic and contribute to the neuronal degeneration and other neurochemical and neurobiochemical changes associated with AD or perhaps other neurodegenerative diseases."
11/01/1997 - "One major oxidation product formed under these conditions, the 5-HT dimer 5,5'-dihydroxy-4,4'-bitryptamine (DHBT), was suggested to have neurotoxic properties and to contribute to neuronal damage in neurodegenerative disorders. "
|2.||Parkinson Disease (Parkinson's Disease)
10/01/1997 - "Irreversible inhibition of mitochondrial complex I by 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxyli c acid (DHBT-1): a putative nigral endotoxin of relevance to Parkinson's disease."
08/15/2008 - "Peroxynitrite induced formation of the neurotoxins 5-S-cysteinyl-dopamine and DHBT-1: implications for Parkinson's disease and protection by polyphenols."
|1.||Serotonin (5 Hydroxytryptamine)
|3.||Peroxynitrous Acid (Peroxynitrite)